Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|31|5077-5092

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.31, 2014-01, pp. : 5077-5092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 273-280

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1305-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 522-537

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2093-2116

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Magnetic Resonance Imaging and Treatment Strategies in Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1622-1629

Bentham Science Publishers

Access to resources Recommend Favorite